After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The new online Learning Center with new content can still be found under the “Training” folder on ...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...